In this regard, MAO B selectivity was pursued to avoid safety issues related to the so-called “cheese-effect” whereas, on the other side, AChE/BChE selectivity was not deemed critical since increasing lines of evidence supported the involvement of BChE in chronic phases of AD thus claiming for BChE as a promising therapeutic target [20]. Here, MAOB is linked to Alzheimer disease.